Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
    Meeting Abstract

    Jaggi, J. S.; Henke, E.; Seshan, S.; Kappel, B.; Chattopadhyay, D.; May, C.; McDevitt, M. R.; Benezra, R.; Scheinberg, D. A.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Lu, S. X.; Cabrera-Perez, J.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Alteration of NK tolerance early post-allogeneic hematopoietic cell transplantation results in NK alloreactivity driven by lack of recipient HLA ligand for donor inhibitory KIR
    Meeting Abstract

    Yu, J.; Chewning, J.; Hsu, K.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Synergy of the purine-scaffold HSP90 inhibitor, PU-H71, with doxorubicin in non-Hodgkin's lymphoma cell lines
    Meeting Abstract

    Varticovski, L.; Wright, M. H.; Caldas-Lopes, E.; Chiosis, G.; Robles, A. I.
    Blood (2007)

    Fulltext@MSK | Save
  • Enhanced anti-tumor efficacy of genetically modified T cells through the up-regulated expression of CD154 (CD40L)
    Meeting Abstract

    Seinstra, B.; Nikhamin, Y.; Brentjens, R.
    Human Gene Therapy (2007)

    Fulltext@MSK | Save
  • The expanding application of lentivirus-mediated erythroid-specific gene therapy
    Meeting Abstract

    Sadelain, M.; Samakoglu, S.; Chang, A.; Lisowski, L.
    Blood Cells, Molecules, and Diseases (2007)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • microRNA-mediated gene regulation effectively restricts in vivo transgene expression in hematopoietic stem cell progeny
    Meeting Abstract

    Papapetrou, E. P.; Kovalovsky, D.; Beloeil, L.; Sant'angelo, D.; Sadelain, M.
    Blood (2007)

    Fulltext@MSK | Save
  • Pilot study of a Wilms tumor protein (WT1) heteroclitic peptide vaccine in patients with myeloid and thoracic neoplasms
    Meeting Abstract

    Maslak, P. G.; Krug, L.; Chanel, S.; Dao, T.; James, L.; Tyson, L.; Bekele, S.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • The importance of the human beta-globin locus control region HS1 and HS4 elements for therapeutic beta-globin gene expression in beta-thalassemic mice
    Meeting Abstract

    Lisowski, L.; Sadelain, M.
    Blood (2007)

    Fulltext@MSK | Save